N/A N=46 Randomized Single-blind Treatment

Quadratus Lumborum Block for Analgesia Following Hip Arthroscopy

Surgery

Bottom Line

View on ClinicalTrials.gov: NCT03557125 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2021

Primary outcome: Primary: Opioid Consumption — 8.1; 11.3 Morphine Milligram Equivalents

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: QL Block (Other); Saline Skin Wheel (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Medical University of South Carolina
Primary completion: Mar 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Opioid Consumption	8.1; 11.3	—
SECONDARY Visual Analog Pain	58.6; 59.6	—
SECONDARY Visual Analog Scale at Time of Post Anesthesia Care Unit Discharge	57.9; 59.2	—
SECONDARY Post Anesthesia Care Unit Duration	99.9; 110.3	—
SECONDARY Patient Satisfaction	7.5; 8.6	—
SECONDARY Opioid Related Side Effects	9; 10	—
SECONDARY Duration of Nerve Block	955.7; 105	—

Summary

Evaluate difference in postoperative opiate consumption when patients do or do not receive a quadratus lumborum block preoperatively for hip arthroscopy.

Eligibility Criteria

Inclusion Criteria

Age greater than or equal to 18 years-old
Undergoing elective hip arthroscopy. Exclusion Criteria
Local anesthetic allergy
Chlorhexidine allergy
Patient weight < 40kg
Patient is currently pregnant
Patient is unable or chooses not to give informed consent
Emergency surgery
Known preoperative substance abuse
Preoperative opioid use for over three months

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03557125). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.